National Multi-sectoral Action Plan on Combatting Antimicrobial Resistance (2017-2020).

The goal of the National Multi-sectoral Action Plan on Combatting Antimicrobial Resistance (2017-2020) is to promote rational use of antibiotics and prevention of the emergence and spread of AMR, improve surveillance of AMR and diagnostics, treatment of antimicrobial infections, and enhance quality of hospital care and outcomes.
In Mongolia, about 700 medicines are registered and commonly used in the agriculture sector and it is vital to take a laboratory test and to ensure quality and safety of animal products consumed. Consumption of animal products with residual antibiotics is causing health risks through food products. The National Action Plan includes activities in accordance with the following six objectives : 1. Establish a governance and ensure multisectoral role to combat antimicrobial resistance, sustainable investment and functioning 2. Strengthen surveillance and diagnostic capacity for AMR and research 3. Reduce the spread of infections through better infection prevention and control 4. Ensure quality and safety of antimicrobial medicines 5. Optimize the use of antimicrobials in the human and animal sectors 6. Raise awareness and understanding of AMR and rational use of the general public, herdsmen and health professionals. Key activities include: Set up a Technical Working Group to coordinate the implementation of the national action plan and discuss every six mounts about the implementation; Sharing information about new registered and rectricted antimicrobials by human and animal drug committties semiannually; Mechanism to link the human and animal drug committees with regular information of antimicrobials established; Upgrade legal environment in Law on Medicines and Medical Devices regarding to prescription only medicines for human and animal; Estimate the annual expenditure of activities in the plan and involve in budget of all participating organizations; Develop a national guideline on determination and surveillance of AM; Accredite human and animal laboratories in cascade and set up mechanism to improve proficiency testing; Improve capacity of TB reference laboratory in line with AMR surveillance; Create a national surveillance and information system for infectious diseases; Set up mechanism that bioequivalence determination should be one the criteria for registration of generic antimicrobials; Revise and update drug registration procedure in human and animal sector; Develop country specific antimicrobial consumption (AMC) methodology and programme for human animal health; Collect AMC data and develop annual report for human and animal health sector; etc.